☰

Archibald Perkins - Publications

Affiliations: 
School of Medicine and Dentistry University of Rochester, Rochester, NY 
Area:
Molecular Biology, Genetics, Oncology
Tree Info Grants Similar researchers PubMed Report error

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Ayoub E, Zhang Y, Andreeff M, Perkins AS. MDS1-EVI1 Complex (MECOM) Activation Promotes Leukemic Stem Cell Quiescence By Upregulating CDKN1C/P57Kip2 Blood. 136: 6-7. DOI: 10.1182/blood-2020-143313  0.321
2018 Ayoub E, Wilson MP, McGrath KE, Li AJ, Frisch BJ, Palis J, Calvi LM, Zhang Y, Perkins AS. EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription. Nature Communications. 9: 4239. PMID 30315161 DOI: 10.1038/S41467-018-06208-Y  0.376
2017 Fenouille N, Bassil CF, Ben-Sahra I, Benajiba L, Alexe G, Ramos A, Pikman Y, Conway AS, Burgess MR, Li Q, Luciano F, Auberger P, Galinsky I, DeAngelo DJ, Stone RM, ... ... Perkins AS, et al. The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia. Nature Medicine. PMID 28191887 DOI: 10.1038/Nm.4283  0.315
2016 Wilson M, Tsakraklides V, Tran M, Xiao YY, Zhang Y, Perkins AS. EVI1 interferes with myeloid maturation via transcriptional repression of Cebpa, via binding to two far downstream regulatory elements. The Journal of Biological Chemistry. PMID 27129260 DOI: 10.1074/Jbc.M115.708156  0.446
2016 Puissant A, Fenouille N, Bassil CF, Ben-Sahra I, Benajiba L, Alexe G, Ramos A, Pikman Y, Burgess MR, Li Q, Luciano F, Auberger P, Galinsky I, DeAngelo DJ, Stone RM, ... Perkins AS, et al. Targeting the Creatine Kinase Pathway in EVI1-Positive Acute Myeloid Leukemia Blood. 128: 523-523. DOI: 10.1182/Blood.V128.22.523.523  0.373
2014 Bard-Chapeau EA, Szumska D, Jacob B, Chua BQ, Chatterjee GC, Zhang Y, Ward JM, Urun F, Kinameri E, Vincent SD, Ahmed S, Bhattacharya S, Osato M, Perkins AS, Moore AW, et al. Mice carrying a hypomorphic Evi1 allele are embryonic viable but exhibit severe congenital heart defects. Plos One. 9: e89397. PMID 24586749 DOI: 10.1371/Journal.Pone.0089397  0.333
2014 Glass C, Wilson M, Gonzalez R, Zhang Y, Perkins AS. The role of EVI1 in myeloid malignancies. Blood Cells, Molecules & Diseases. 53: 67-76. PMID 24495476 DOI: 10.1016/J.Bcmd.2014.01.002  0.575
2013 Zhang Y, Owens K, Hatem L, Glass CH, Karuppaiah K, Camargo F, Perkins AS. Essential role of PR-domain protein MDS1-EVI1 in MLL-AF9 leukemia. Blood. 122: 2888-92. PMID 24021671 DOI: 10.1182/Blood-2012-08-453662  0.545
2013 Glass C, Wuertzer C, Cui X, Bi Y, Davuluri R, Xiao YY, Wilson M, Owens K, Zhang Y, Perkins A. Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia. Plos One. 8: e67134. PMID 23826213 DOI: 10.1371/Journal.Pone.0067134  0.537
2013 Zhang Y, Cui X, Wuertzer CA, Perkins AS. EVI1, A Potential Regulator Of CEBPA; A Contributory Mechanism In Leukemogenesis? Blood. 122: 2495-2495. DOI: 10.1182/Blood.V122.21.2495.2495  0.38
2012 Bresnick EH, Katsumura KR, Lee HY, Johnson KD, Perkins AS. Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies. Nucleic Acids Research. 40: 5819-31. PMID 22492510 DOI: 10.1093/Nar/Gks281  0.393
2011 Zhang Y, Sicot G, Cui X, Vogel M, Wuertzer CA, Lezon-Geyda K, Wheeler J, Harki DA, Muzikar KA, Stolper DA, Dervan PB, Perkins AS. Targeting a DNA binding motif of the EVI1 protein by a pyrrole-imidazole polyamide. Biochemistry. 50: 10431-41. PMID 22039883 DOI: 10.1021/Bi200962U  0.367
2011 Zhang Y, Stehling-Sun S, Lezon-Geyda K, Juneja SC, Coillard L, Chatterjee G, Wuertzer CA, Camargo F, Perkins AS. PR-domain-containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function. Blood. 118: 3853-61. PMID 21666053 DOI: 10.1182/Blood-2011-02-334680  0.331
2010 Halene S, Gaines P, Sun H, Zibello T, Lin S, Khanna-Gupta A, Williams SC, Perkins A, Krause D, Berliner N. C/EBPepsilon directs granulocytic-vs-monocytic lineage determination and confers chemotactic function via Hlx. Experimental Hematology. 38: 90-103. PMID 19925846 DOI: 10.1016/J.Exphem.2009.11.004  0.337
2008 Qiu Y, Lynch J, Guo L, Yatsula B, Perkins AS, Michalak M. Regulation of the calreticulin gene by GATA6 and Evi-1 transcription factors. Biochemistry. 47: 3697-704. PMID 18303859 DOI: 10.1021/Bi702524V  0.373
2008 Perkins AS, Campo JJd, Xiao Y, Zhang Y, Lin SJ, Dudley J, Tuck D, Yatsula B. EVI1 Blocks Apoptosis in DA-1 Myeloid Leukemia Cells Via Enhanced Transcription of the Prosurvival Gene Bcl2a1 (A1) Blood. 112: 3805-3805. DOI: 10.1182/Blood.V112.11.3805.3805  0.333
2008 Sicot G, Vogel M, Zhang Y, Harki DA, Lezon-Geyda K, Dervan P, Perkins AS. Development of a Novel Polyamide-Based Agent to Inhibit EVI1 Function Blood. 112: 2660-2660. DOI: 10.1182/Blood.V112.11.2660.2660  0.411
2006 Boyd KE, Xiao YY, Fan K, Poholek A, Copeland NG, Jenkins NA, Perkins AS. Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR. Blood. 107: 733-41. PMID 16204320 DOI: 10.1182/Blood-2003-05-1626  0.364
2006 Perkins AS, Lin S, delCampo J, Camargo F, Lezon-Geyda K. Analysis of a LacZ Knock-In Allele of MDS1 Indicates a Critical Role in Hematopoietic Development. Blood. 108: 444-444. DOI: 10.1182/Blood.V108.11.444.444  0.318
2005 Yatsula B, Lin S, Read AJ, Poholek A, Yates K, Yue D, Hui P, Perkins AS. Identification of binding sites of EVI1 in mammalian cells. The Journal of Biological Chemistry. 280: 30712-22. PMID 16006653 DOI: 10.1074/Jbc.M504293200  0.43
2005 Yuasa H, Oike Y, Iwama A, Nishikata I, Sugiyama D, Perkins A, Mucenski ML, Suda T, Morishita K. Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression. The Embo Journal. 24: 1976-87. PMID 15889140 DOI: 10.1038/Sj.Emboj.7600679  0.458
2005 Perkins AS, Xiao Y, Lezon-Geyda K, Lin S, Camargo F, Tuck D, Yatsula B. Role of EVI1 in Cell Cycle Regulation: Relevance of Specific Target Genes. Blood. 106: 1614-1614. DOI: 10.1182/BLOOD.V106.11.1614.1614  0.499
2002 Ma X, Husain T, Peng H, Lin S, Mironenko O, Maun N, Johnson S, Tuck D, Berliner N, Krause DS, Perkins AS. Development of a murine hematopoietic progenitor complementary DNA microarray using a subtracted complementary DNA library. Blood. 100: 833-44. PMID 12130493 DOI: 10.1182/Blood.V100.3.833  0.348
1998 Nottoli T, Hagopian-Donaldson S, Zhang J, Perkins A, Williams T. AP-2-null cells disrupt morphogenesis of the eye, face, and limbs in chimeric mice Proceedings of the National Academy of Sciences of the United States of America. 95: 13714-13719. PMID 9811866 DOI: 10.1073/Pnas.95.23.13714  0.307
1998 Kim JH, Hui P, Yue D, Aycock J, Leclerc C, Bjoring AR, Perkins AS. Identification of candidate target genes for EVI-1, a zinc finger oncoprotein, using a novel selection strategy. Oncogene. 17: 1527-38. PMID 9794230 DOI: 10.1038/sj.onc.1202331  0.345
1996 Lopingco MC, Perkins AS. Molecular analysis of Evi1, a zinc finger oncogene involved in myeloid leukemia. Current Topics in Microbiology and Immunology. 211: 211-22. PMID 8585952 DOI: 10.1007/978-3-642-85232-9_21  0.498
1992 Stanton BR, Perkins AS, Tessarollo L, Sassoon DA, Parada LF. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes & Development. 6: 2235-47. PMID 1459449  0.307
1991 Perkins AS, Fishel R, Jenkins NA, Copeland NG. Evi-1, a Murine Zinc Finger Proto-Oncogene, Encodes a Sequence-Specific DNA-Binding Protein Molecular and Cellular Biology. 11: 2665-2674. PMID 2017172 DOI: 10.1128/Mcb.11.5.2665  0.311
Show low-probability matches.